Hepatic and urinary Flashcards

1
Q

diagnostic tests for hepatic disease- Hepatic enzymes

A

– hepatocellular (ALT, GLDH, AST) vs cholestatic (ALP, GGT). They may be increased with hepatocellular damage or cholestasis respectively (remember non hepatic causes of elevations are very common).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

diagnostic tests for hepatic disease- diagnostic tests for hepatic disease

A

increased in hepatic inflammation (globulin) or neoplasia (globulin)
- decreased in severe liver disease (albumin and globulin) e.g portosystemic shunt (PSS).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

diagnostic tests for hepatic disease- Bilirubin

A

pre-hepatic, intra-hepatic, post-hepatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

diagnostic tests for hepatic disease- Bile acid stimulation test

A

(do not perform in icteric patients)– test of liver function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

diagnostic tests for hepatic disease- increased in cholestasis
-

A

decreased in severe liver disease, portosystemic shunt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

diagnostic tests for hepatic disease- Blood glucose

A

decreased in liver failure, hepatic tumours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

diagnostic tests for hepatic disease- Coagulation factors

A

may be prolonged in hepatic failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

diagnostic tests for hepatic disease- Haematology

A

mild non regenerative anaemia in chronic disease; microcytosis in PSS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

diagnostic tests for hepatic diseas- Urinalysis

A

bilirubinuria suggest hepatobiliary disease (especially cats); urate uroliths in PSS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

diagnostic tests for hepatic disease- Imaging

A

radiography,
ultrasonography- most usefull inforst opinion, CT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

diagnostic tests for hepatic disease- sampling

A

Cytology (FNA), biopsy (percutaneous
u/s guided trucut, vs
biopsy at laparoscopy
vs biopsy at
exploratory laparotomy).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Rex, 10 year old MN Labrador retriever, fully vaccinated, no history of travel outside of the UK. Progressive history over the past few months of decreased appetite, lethargy and diarrhoea.

Physical examination: there is a weight loss of 4Kg since last checked 6 months ago.

he is diagnosed with chronic hepatitis, how would you go about disgnosisng this

A

Problem list: diarrhoea
weight loss
lethargy and decreased appetite are likely to be secondary problems.

You decide to perform haematology, biochemistry and urinalysis. (Haematology shows a mild, non-regenerative anaemia. Biochemistry shows elevated ALP and ALT and reduced albumin. Urinalysis: USG is 1.036 and no abnormalities are identified.)

this shows hepatic disease likley

Abdominal ultrasonography is performed to further investigate your ddx. From this, you identify that:

The liver is subjectively small.
The liver is hyperechoic compared to the spleen (normally, it is hypoechoic).
The liver appears heterogenous with small hypoechoic nodules.

Abdominal ultrasonography is performed to further investigate your ddx. From this, you identify that:

The liver is subjectively small.
The liver is hyperechoic compared to the spleen (normally, it is hypoechoic).
The liver appears heterogenous with small hypoechoic nodules.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

chronic hepatitis (CH) treatment

A

lack of evidence, ACVIM consensus statement from 2019 suggests a combination of ursodeoxycholic acid; SAMe; vitamin E; and possibly immunosuppressive agents (prednisolone; azathioprine; cyclosporine).

cause isiopathic so difficult

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

History: Buttons, 9 yo FE DLH. Indoor cat only, fully vaccinated. No history of travel outside of the UK. A three day history of acute onset lethargy and anorexia.

Physical exam: QAR, rectal temperature is elevated, 39.6, mucous membranes are icteric, she has a slight skin tent and tacky mucous membranes. HR is 180 and RR is 28 bpm. The rest of the physical exam is unremarkable.

she is diagnosed with a gall bladder infection, how would you go about doing this?

A

You decide to perform biochemistry, haematology and urinalysis. (Biochemistry show an increase in ALT, ALP, GGT and bilirubin, and a mildly elevated urea.. Haematology shows a left shift neutrophilia (meaning increased numbers of immature/band neutrophils) and there is a mildly elevated Hct and total RBC. Urinalysis is positive for bilirubin.)

findings suggest a hepatic or post hepatic cause

Ultrasonography identifies a diffuse patchy echogenicity and a thickened gall bladder wall and distension of the bile duct, but rules out extrahepatic biliary obstruction.

Biopsy performed by percutaneous ultrasound-guided trucut, following normal coagulation time results.

Treatment: antimicrobials, ideally based on C & S from bile or hepatic tissue. If not possible, E.coli is the most common isolate. Amox/clav would be a sensible choice and supportive treatment (IVFT, SAMe, UCDA, analgesia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Icterus/jaundice

A

Also termed hyperbilirubinaemia. It is a yellow discolouration of the body tissue resulting from the accumulation of excess bilirubin.

Pre-hepatic: enhanced bilirubin formation, usually due to haemolysis. Ddx include primary IMHA and secondary IMHA e.g feline haemotropic mycoplasmosis (FHM, previously termed feline infectious anaemia or haemobartonellosis).

Hepatic: the liver is unable to clear the daily bilirubin load due to impaired hepatic function. Ddx e.g neutrophilic and lymphocytic cholangitis (cats); FIP (cats); leptospirosis (dogs); chronic canine hepatitis; hepatic lipidosis (cats); diffuse neoplasia.

Post-hepatic: biliary system is unable to excrete bilirubin via the FGI tract, ddx include biliary obstruction (ddx e.g cholelithiasis; severe pancreatitis, or e.g ruptured common bile duct or gallbladder).

Haematology (regenerative/pre regenearative anaemia) is key is helping to identify pre-hepatic causes, and imaging and biochemistry to differentiate hepatic (usually ALT is proportionately higher than ALKP) from post-hepatic (ALKP proportionately higher than ALT) causes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pre-hepatic jaundice

A

enhanced bilirubin formation, usually due to haemolysis. Ddx include primary IMHA and secondary IMHA e.g feline haemotropic mycoplasmosis (FHM, previously termed feline infectious anaemia or haemobartonellosis).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

hepatic jaundice

A

the liver is unable to clear the daily bilirubin load due to impaired hepatic function. Ddx e.g neutrophilic and lymphocytic cholangitis (cats); FIP (cats); leptospirosis (dogs); chronic canine hepatitis; hepatic lipidosis (cats); diffuse neoplasia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

post-hepatic jaundice

A

biliary system is unable to excrete bilirubin via the FGI tract, ddx include biliary obstruction (ddx e.g cholelithiasis; severe pancreatitis, or e.g ruptured common bile duct or gallbladder).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

History: Rocky, A 16 week old ME Yorkshire Terrier. Small compared to litter mates, seems disorientated at times, drinks a lot.

Physical exam: neurological exam: slightly reduced mentation, otherwise no neurological deficits are detected, small for age but the rest of the examination is unremarkable.

he is daignosed with a protosystemic shunt- how would you go about doing this?

A

You perform haematology which shows a mild anemia with a microcytosis (low MCV). Biochemisty shows a reduced urea and albumin and elevated ALT and AST. Urinalysis shows a low USG and is otherwise normal.

You perform a bile acid stimulation test which shows that bile acids are elevated. This is suggestive of a porto systemic shunt.

Following discussion with the owner, referral is arranged, where a CT scan confirms an extrahepatic portosystemic shunt between the portal vein and the caudal vena cava.

Treatment: following medical stabilization, surgery is performed to close the shunt. Rocky makes an excellent recovery, and survival rates are around 95%.

What if surgery had not been an option?
Medical treatment includes: - diet change, to reduce the amount of protein and feed only high quality, highly digestible protein diets.
- lactulose (decreases ammonia absorption, unfavourable environment for toxin producing bacteria to reduce ammonia production)
- sometimes antibiotics (metronidazole, amoxicillin), to alter the bacterial population of the GI tract away from toxin producing bacteria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

treatment fo portosytemic shunt

A

Treatment: following medical stabilization, surgery is performed to close the shunt. Rocky makes an excellent recovery, and survival rates are around 95%.

What if surgery had not been an option?
Medical treatment includes: - diet change, to reduce the amount of protein and feed only high quality, highly digestible protein diets.
- lactulose (decreases ammonia absorption, unfavourable environment for toxin producing bacteria to reduce ammonia production)
- sometimes antibiotics (metronidazole, amoxicillin), to alter the bacterial population of the GI tract away from toxin producing bacteria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Interventions for hepatic disease

A

Specific diagnosis vs supportive care

Supportive care:
Diet: high quality protein, highly digestible: prescription hepatic diets, possibly with protein supplementation (cottage cheese, chicken) or prescription diet for GI disease. Monitor protein on biochemistry and body weight.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Interventions for hepatic disease- Antioxidants

A

oxidnet stress occurs in liver due to decrease blood flow?
limited evidence

     - SAMe (S-adenosylmethionine)
     - Vitamin E
      - Silymarin (milk thistle)
      - Zinc
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Interventions for hepatic disease-Choleretics and bile acid modifiers

A
  • UDCA (ursodeoxycholic acid)
    Stimulates bile flow which reduces cell
    damage and oxidative stress + immunomodulatory action.
    Contraindicated in biliary obstruction - risk gall bladder rupture.

offlicence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Interventions for hepatic disease-Antimicrobials

A

Use only when history, physical exam and
further diagnostics are suggestive of
an infectious aetiology

A good example of when they are indicated:
Leptospirosis (take urine/blood sample for PCR test
before starting antimicrobials to avoid false negatives). Penicillins
or doxycycline.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Interventions for hepatic disease- Anti-inflammatories (corticosteroids)

A

Indications
Biopsy evidence of ongoing inflammation, e.g lymphocytic cholangitis in cats.
No fibrosis or early/mild fibrosis
Infectious causes ruled out as far as possible.

Contraindications
Known of suspected infectious cause
Advanced, bridging fibrosis or non-inflammatory fibrosis (no benefit and increased risk portal hypertension (PH))
Ascites (in animals with liver disease this is usually caused by portal hypertension. CS can precipitate GI ulceration and HE, and increase water retention).
HE (CS lead to protein catabolism and production of ammonia, worsening HE)
Acute hepatitis (usually infectious or toxic aetiology, and high risk GI ulceration)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

portal hypertension …..

A

PH occurs due to increased resistance in the portal circulation and/or increased portal venous flow.

Causes can be pre-hepatic, hepatic or post-hepatic

Portal pressure is rarely measured directly (definitely not in first opinion practice!), and the diagnosis is inferred from the development of complications of hepatic disease, including multiple acquired PSS, ascites and HE.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Hepatic surgery, cases of hepatic compromise-

A

Pre-surgical considerations-
Anaemia
Hypoproteinaemia
Hepatic encephalopathy
Extended coagulation times
Ascites
Dehydration

Prophylactic antibiotics
A large ventral midline abdominal incision from xiphoid cartilage caudally. The falciform ligament should be removed.
Balfour abdominal retractors
An assistant can retract caudally on stay sutures placed in the greater curvature of the stomach to facilitate manipulation of the liver.
Common first opinion hepatic surgeries: biopsy; partial lobectomy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Hepatic biopsy at exploratory laparotomy

A

For peripheral lesions: - place a loop of absorbable suture around the tip of the liver lobe and tie tightly (remember surgeons knot). Empty suture packet can be used as a cutting board. Resect approx. 5mm distal to the suture, place in formalin and obtain C & S sample from hepatic tissue.

For focal lesions: punch biopsy. Haemorrhage can be really well with e.g lysosypt (a collagen haemostat) which is left in place. Place biopsy sample in formalin and C & S as above.

Both techniques: ensure haemostasis before
routine abdominal closure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

when to refer for hepatic disease

A

Portosystemic shunts
Definitive diagnosis?
Imaging?
Anesthetic and surgical training, e.g biliary surgery
Biopsy – percutaneous ultrasound
guided, laparascopic
Inpatient care provision in first opinion
practice– registered veterinary nurses,
OOH arrangements etc.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

infectious causs of diarrhoea in foals age 0-14 days

A

SEPTIOCEMIA!!

Viral infection-
Rotavirus
Coronavirus/adenovirus (Uncommon, usually seen in immunocompromised foals)

Bacterial infection-
Clostridium difficile
Clostridium perfringens
Escherichia coli (rare)
Salmonella

Fungal Infection -
Candida/Mucor spp. (Rare: usually seen in
immunocompromised foals)

Protozoal infection-
Cryptosporidium spp

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

non-infectious causs of diarrhoea in foals age 0-14 days

A

Foal heat diarrhoea

Nutritional causes (such as errors in feeding or lactose intolerance)

Perinatal asphyxia syndrome/ HIE

Necrotising enterocolitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

non-infectious causs of diarrhoea in foals age2 weeks- 2 months

A

Nutritional causes (such as errors in feeding or lactose intolerance)

Luminal irritants (such as sand enteritis)

Gastric ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

infectious causs of diarrhoea in foals age > 2 months

A

Viral infection-
Rotavirus
Coronavirus/adenovirus (Uncommon, usually seen in immunocompromised foals)

Bacterial infection-
Clostridium difficile
Clostridium perfringens
Escherichia coli (rare)
Salmonella
Lawsonia intracellularis
Rhodococcus equi ( rare: more commonly respiratory disease)

Fungal Infection -
Candida/Mucor spp. (Rare, usually seen in
immunocompromised foals)

Protozoal infection-
Cryptosporidium spp

Parasitic infection -
strongyloides westeri (uncommon)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

infectious causs of diarrhoea in foals age2 weeks- 2 months

A

Viral infection-
Rotavirus
Coronavirus/adenovirus (Uncommon, usually seen in immunocompromised foals)

Bacterial infection-
Clostridium difficile
Clostridium perfringens
Escherichia coli (rare)
Salmonella

Fungal Infection-
Candida/Mucor spp. (Rare: usually seen in
immunocompromised foals)

Protozoal infection-
Cryptosporidium spp

Parasitic infection-
strongyloides westeri (uncommon)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

non-infectious causs of diarrhoea in foals age > 2 months

A

Nutritional causes (such as errors in feeding or lactose intolerance)

Luminal irritants (such as sand enteritis

Gastric ulceration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Foal heat diarrhoea ( 75-80% foals)

A

Self-limiting condition in foals aged 5 days to 15 days
No signs of systemic disease, and continue to suckle well
Aetiology remains speculative
Changes in mares’ milk around time of first oestrus?? Unlikely as occurs in orphan foals too.
Maturational changes in bacterial intestinal flora considered the most likely cause

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Perinatal asphyxia syndrome (PAS)/ HIE in foals

A

Risk factors, dystocia, inadequate oxygenation following delivery
Hypothesis: hypoxic injury of the gastrointestinal tract may lead to ischaemic damage to the enterocytes.
May lead to diarrhoea, gastrointestinal reflux, intolerance of enteral feeding or abdominal distension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Necrotizing Enterocolitis (common in human babies)- in foals

A

Pathophysiology: Multifactorial. complex interaction of immaturity, gastrointestinal mucosal injury, enteral milk feeding and bacterial invasion
Severe weakness, inability to stand, colic, ileus, gastric reflux, intolerance to enteral feeding, shock signs.
Even with intensive care, the prognosis is poor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Nutritional causes/ luminal irritants of diarhoa in foals

A

Ingestion of abnormal material e.g. sand
Incorrect formulation of milk replacer (orphan foals)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

gastric ulceration in foals

A

D++ may be seen in association with gastric ulceration in foals.
Concurrent clinical signs bruxism, ptyalism, dorsal recumbency, colic, ill thrift, poor hair coat and lethargy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

rota virus in foals

A

Most commonly detected infectious agent in foals.
Incubation period 1-4 days
Clinical disease: ranges from mild self-limiting diarrhoea to profuse watery diarrhoea with significant dehydration and electrolyte derangements. Milder disease in older foals
Most common 5-35 days of age.
Virus infects the epithelial tips of the villi of the small intestine, resulting in cell lysis, blunting of villous tips and decreased production of lactase.
Leads to lactose intolerance and prolonged diarrhoea.
Faecal-oral transmission. Highly contagious. Can persist in the environment for several months. Infected foals shed virus for up to 10 days.
Vaccination of pregnant mares may reduce outbreaks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

clostridium infection as a cause of diarrhoea in foals

A

Clostridium difficile and Clostridium perfringens (both can rarely be found in normal foals)
As with adults’ development of disease is associated with toxin producing strains of the bacteria.
Sporadic cases and “outbreaks” can occur.
Risk factors: previous use of antimicrobials, stressors e.g., hospitalisation, travel and weaning.
Can result in severe haemorrhagic enterocolitis in foals, with rapid progression and high mortality rates
Clostridium difficile is commonly associated with diarrhoea in humans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

salmonella infection as a cause of diarrhoea in foals

A

Well recognised pathogens associated with diarrhoea and septicaemia in foals
Clinical signs include moderate to severe diarrhoea, pyrexia, depression and inappetence.
Foals with salmonellosis should be monitored closely for evidence of sepsis and for signs of localised infections such as uveitis, synovitis and osteomyelitis.
Unlike in adult horses all neonatal foals with enteric salmonellosis should be treated with systemic antimicrobials
Zoonotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Lawsonia intracellularis
infection as a cause of diarrhoea in foals

A

Infection via accidental oral ingestion, main reservoir of infection wildlife.
Faecal shedding for 7‐17 days in infected foals 1-2 weeks organism survival in environment
Primarily affects weanling and yearling horses between August and February
Clinical signs: include lethargy, weight loss, pyrexia, diarrhoea and peripheral oedema.
Marked hypoproteinaemia and hypalbuminaemia, and ultrasonographic evidence of small intestinal thickening
Off label use of pig vaccine has been shown to be protective against clinical disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Rhodococcus equi
infection as a cause of diarrhoea in foals

A

Primarily a respiratory pathogen, can cause extra-pulmonary disease including enterocolitis, abdominal abscessation, peritonitis and hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Parasitic Infection (uncommon)
infection as a cause of diarrhoea in foals

A

S westeri infects foals early in its life (transmission of larvae via ingestion of the mare’s milk), but its role in diarrhoea is questionable.
Cryptosporidium parvum has been identified in the faeces of foals with diarrhoea, primarily in those less than 1 month of age. Contagious and zoonotic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Approach to diagnosis in Foal diarrhoea

A

Thorough history and clinical examination
Further laboratory testing is dependent on the age of the foal and severity of the clinical signs
Baseline clinical pathology:
Haematology
Proteins
Inflammatory markers
Serum Electrolytes
Renal enzymes/urinalysis (SG If less than 1.010 foal is hydrating itself)- foal being able to urinate in the first place is important in itself
Plasma Lactate
IgG (in young foals)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

determining the aetiology of foal diarhoea

A

Faecal testing is important from a biosecurity point of view.
Tests based on the most likely agent given the age of foal
Many commercial labs offer “diarrhoea panels” but you should be happy about the most appropriate tests given the context of each case.
In many foals with diarrhoea, more than one pathogen can be involved.
A positive test does not always confirm that the particular agent is the underlying cause of the diarrhoea, as several pathogens can be found in healthy foals as well.

Additional diagnostics – hospital setting
Abdominal ultrasonography:
Assess intestinal wall thickness, intestinal motility, stomach size, volume and appearance of peritoneal fluid in addition to umbilical structures in younger foals (important focus of infection)

Abdominal radiography
Sand /gas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

fluids in foals

A

In foals with evidence of hypovolaemia fluids are required.
Enteral (very mild cases with no reflux)
Intravenous (most cases):
The rate, volume and type of fluid administered depends on the degree of hypovolaemia, cardiovascular status and plasma protein concentration
Foals are not tolerant of large sodium loads, so hypertonic saline contraindicated
For initial resuscitation in almost all cases a balanced crystalloid (such as lactated ringers) is appropriate.
Common approach 10–20 ml/Kg over 20–30 minutes, and then repeat as indicated by response to therapy (normalisation of tachycardia, improved mentation, passing urine etc.)
However, foals are not tolerant of excessive fluid volumes so care must be taken to avoid fluid overload.
Frequent reassessment should be performed and used to guide fluid therapy (PCV/TP/Urine SG/ clinical signs)

colloids-
Synthetic colloids not advised: have been associated with the development of coagulopathies, renal failure and an ultimately worse outcome in humans
Hyperimmune plasma (our best option) provides plasma proteins but also immunoglobulins.
Essential in foals with failure of passive transfer, but any sick foal can rapidly consume immunoglobulins even if initially adequate concentrations.

Electrolytes
Electrolyte imbalances and acid-base disturbances are common
Correction crucial for recovery and is typically performed via intravenous fluid therapy
In more mild cases oral supplementation may be sufficient.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

When should we use antibiotics in a case of foal diarhoea?

A

Foals under 2 weeks
Clostridial infection
Salmonella
Lawsonia

Choice of specific antibiotics and dose important
Consideration should be given to hydration status and renal function prior to starting any potentially nephrotoxic antimicrobials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

antimicrobials for a treatment of Undifferentiated D++ in neonate / Salmonella
foal diarhoea

A

amikacin (25–30 mg/kg every 24 hours, i.v. or i.m.) and ampicillin (20 mg/kg every 6–8 hours, i.v. or i.m.)
or
ceftiofur (5–10 mg/kg, every 6–12 hours, i.v. or i.m.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

antimicrobials for a treatment of Clostridial infection
foal diarhoea

A

Metronidazole (dose varies with age)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

antimicrobials for a treatment of Lawsonia intracellularis

foal diarhoea

A

oxytetracycline (5-10mg/kg i.v, every 12 hours).
Or
macrolide antimicrobials. (***Care re colitis in older animals with macrolides)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Analgesia therapy in foals with dirhoea

A

Analgesia
Foals with D++ may show colic signs associated with inflammation / distension
NSAIDs such as meloxicam/ flunixin (care re renal effects and effects on epithelial health)
Butorphanol 0.01-0.04mg/kg i.v.
Buscopan (N-butylscopolamonium bromide) 0.3mg/kg i.v.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

Gastric ulcer therapy in foals

A

Prophylactic use of anti-ulcer medication is controversial in neonates/ less so older foals
Use of proton pump inhibitors has been associated with the development of diarrhoea in hospitalised foals (Furr et al, 2012)
Sucralfate 20-40mg/kg po every 6 hour is an alternative option in neonates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Additional therapies in foal diarhoea

A

Intestinal binding agents -
Di-tri-octahedral smectite (Bio-Sponge; Platinum Performance) binds clostridial toxin

Lactase-
In cases where lactose intolerance is suspected (1 tablet 6-8 times daily)

Probiotics -
Not recommended. Have been shown to be associated with diarrhoea

Nursing care -
Hygiene and cleanliness
Hindquarters and tail
Mare’s udder (strip out)

55
Q

Hygiene and Biosecurity with infectioius disease in horses

A

If an infectious aetiology is suspected strict biosecurity measures need to be put in place
Protect other horses and humans (clostridia / salmonella = zoonosis)
Isolate affected animals
Separate stable equipment / ideally a separate muck heap
Wear PPE (overalls/ boot covers and gloves)
Foot dip/ sanitise hands prior to leaving (alcohol gel not effective vs clostridial spores)

Foot dips – Bleach or Virkon
Gross contamination with organic material deactivates bleach – will need to be changed

Cleaning and disinfection (after disease)
Remove bedding /wash walls and floor to remove organic material. Detergents are used to emulsify fats and loosen organic matter
Clostridial spores and salmonella resistant to cleaning but this will reduce contamination dramatically

56
Q

Acute Kidney Injury (AKI)

A

Any ‘sudden’ structural OR functional damage to the kidneys as defined by the IRIS criteria

the progression of AKI can either result in:
Complete Resolution
Chronic Kidney Disease (CKD)
Death or Euthanasia

Can be-
Ischaemic
Infectious
Toxic
Obstructive

57
Q

Chronic Kidney Disease (CKD)-

A

Any structural OR functional damage to the kidneys that has been present, and stable, for at least three months

58
Q

Acute on Chronic Kidney Disease

A

Any episode of AKI that is superimposed on top of pre-existing CKD
Can be in cases of ‘known’ CKD – i.e., come in for a ‘uraemic crisis’- Not uncommon in cats with CKD where for one reason or another, they become more uraemic/stop drinking and become dehydrated/anorexic. Often, a short period of hospitalisation with sufficient fluid therapy (typically in the optimisation phase) rehydrates them an improves appetite and can usually be discharge home soon after. As discussed in CKD lectures some clients wil opt for subcutaneous fluid adminstraiton at home or placement of an oesophagosotmy tube

Sometimes can present as the first recognition of any kidney disease and can be difficult to differentiate from ‘just’ an AKI

The two main methods of assessing for the presence of ‘acute on chronic’ kidney disease are:
Body condition score/Muscle condition score (evidence of chronic pathology)
Ultrasonography of the kidney demonstrating chronic changes
Suspected higher incidence of pyelonephritis in acute on chronic cases – urine culture!
Overall suspected ‘poorer’ prognosis than AKI

59
Q

Azotaemia

A

An increase in Creatinine and/or urea above their reference intervals

60
Q

Uraemia-

A

The clinical signs as a result of azotaemia (e.g. nausea/anorexia)

61
Q

Renal failure

A

A rarely used term where AKI or CKD has progressed to the stage that the kidneys are unable to maintain ‘normal’ homeostasis with regards to hydration, electrolyte, or acid-base abnormalities.

62
Q

Uraemic crisis

A

An ‘acute on chronic’ flair-up resulting in increased uraemic toxins and signs of clinical illness

63
Q

progression of chronic kidney disease in small animals

A

The classic situation is progressive renal inflammation in the background that slowly ‘burns away’ at the kidney and there is a steady decline in nephrons. This happens ‘in the background’ and it is not until roughly 75% of nephrons are lost when creatinine starts to increase. It is not until even further than that when signs of uraemia start to develop and the animal is presented as being unwell. Although interventions can be started there is usually on-going progressive decrease in renal function and progressive worsening of CKD. This progressed to a point where the animal either dies or is euthanised

Often will be absent of clinical signs in the background until a significant number of nephrons lost and then clinical signs develop

This will never reverse

We can also have the situation where a health kidney experiences an episode of AKI (for varying causes) which causes a sudden reduction in kidney function. If this AKI does not fully resolve it can progress to CKD and in most cases (but not all) will then continue on the ‘classic’ CKD trajectory of on-going renal inflammation and a progressive decline towards an end-stage kidney

64
Q

Chronic Kidney Disease (CKD)- Neoplasia

A

We can also have other causes of renal disease that are classed as ‘CKD’. For example, if an animal has a tumour on the kidney (strictly speaking – for 3 months) then it is still classed as CKD. Overtime, this tumour will progress and result in an end-stage kidney (or death due to the metastasis etc.)

65
Q

Chronic Kidney Disease (CKD)- Polycystic Kidney Disease

A

Similar to neoplasia, we can also see this with polycystic kidney disease (typically persian cats) where cysts develop due to a mutation in the gene PKD1. Over time (often years!) these cysts increase in number and size resulting in reduced renal function and progression towards end-stage CKD. As these are present for a period of 3m+ they are a cause of CKD

66
Q

Chronic Kidney Disease (CKD)- Juvenile Onset Chronic Kidney Disease (JOCKD)

A

We can also see this with Juvenile Onset Chronic Kidney disease (previously known as renal dysplasia). In JOCKD, there is a presumed congenital abnormality to the kidneys that contributes to on-going progressive deterioration in kidney function. As this is present for more than 3 months duration it is classed as CKD. Over time, this can often result in progressive renal dysfunction towards end-stage CKD

67
Q

Chronic Kidney Disease (CKD)- Glomerular Disease

A

One of the causes of CKD is glomerular disease (disease pertaining to the glomeruli of the nephrons) which is more commonly seen in dogs cf. cats (see glomerular disease/proteinuria lectures). As the glomeruli leak excess protein into the renal tubules this results in inflammation and a progressive decline in renal function. Again, as this has been present for more than 3 months it is classed as CKD.

e.g- Immune Complex Mediated
Non-Immune Complex Mediated
Amyloidosis

68
Q

Diagnosis of Chronic Kidney Disease

A

Any structural or functional change to the kidneys that is present for at least 3 months is classed as ‘chronic kidney disease’
Markers of glomerular filtration (GFR) are typically used to assess the presence and severity (creatinine/urea/SDMA)
Urinalysis changes are also included (e.g., proteinuria)
Imaging changes are also included (e.g., structural changes)
Improvement in renal function is NOT generally seen in chronic kidney disease*

The vast majority of cause of CKD are NOT reversible. Although we may see an improvement in creatinine, this is often the result of reduced muscle mass or fluid therapy rather than a true improvement in renal function. In the majority of cases of CKD, renal function will continue to decrease over time towards an end-stagfe kidney. There are, however, a notable number of cases where this does not occur and CKD is present, but stable for long periods of time.

For a diagnosis of CKD, the changes must have been present, and ideally stable, for at least three months
Until that point they are still technically classed as AKI
Some changes will essentially lead to a diagnosis of CKD on discovery:
1- Evidence of chronic kidney disease on ultrasound or other imaging modalities
2- Evidence of renal neoplasia or PCKD on imaging
3- Azotaemia alongside poor BCS/MCS
Otherwise, causes should be investigated and then reassessed at the three-month mark to assign a CKD stage

69
Q

Markers of GFR

A

GFR can be accurately assessed using methods such as Iohexol or Inulin clearance – rarely performed in practice
Proxy-biomarkers are more commonly used that approximate GFR
Creatinine – produced in the muscles and filtered by the kidneys
Urea – produced in the liver and excreted by the kidneys (non-specific)
SDMA – produced by the majority of the cells in the body and filtered by the kidneys (less-affected by assay interference)
ALL are affected by pre, intra, and post-renal factors

Although the concentration of urea in the plasma can be reflective of GFR – it is heavily influenced by other factors such as hydration status, recent consumption of a meal,. Pyrexia, and gastrointestinal bleeding among others. Consequently, I do not put much emphasis on UREA – focus more on creatinine.,

70
Q

Creatinine for monitoring CKD

A

Creatinine is the main GFR marker to assess renal function
Produced in the muscles and filtered by the kidneys
Does not tend to increase until ~75% of functional nephrons lost
Also affected by muscle mass, hydration status, and hyperthyroidism
Can be notably ‘falsely’ reduced in animals with loss of muscle mass
Part of the IRIS staging system
Best used for monitoring progression of CKD

71
Q

Diagnosis of Chronic Kidney Disease- SDMA

A

S-Dimethyl Arginine (SDMA) is produced by the majority of the cells in the body and filtered by the kidneys
Will typically increase prior to creatinine during the course of CKD
Minimally affected by external factors (not affected by muscle mass)
Better used to diagnose CKD – less suited to on-going monitoring (cf. creatinine)
There is very little merit in measuring SDMA when creatinine is increased*

The exception being to more accurately assess the IRIS stage when there is marked muscle loss which may falsely reduce the creatinine concentration. SDMA will be less affected by muscle mass so will likely be more representative of true decreased in renal function

72
Q

Diagnosis of Chronic Kidney Disease- Filtration Markers

A

As there is a progressive decline in nephrons (and thus GFR/renal function) there is a lag period before picking this up on blood work. In theory, if we did iohexhol/inulin clearance (more of a research technique) we would pick this up much sooner (?although it is unclear whether this has a clinical benefit?). However, in clinical practice this is rarely available.
Generally speaking, SDMA is typically the first biomarker to increase outside of its reference interval and this typically precedes creatinine by a number of months.
Following this we see a decrease in USG (loss of concentrating ability) – HOWEVER it must be remembered that a number of animals (especially cats) are able to maintain their urine concentrating ability despite a marked reduction in renal function.
Finally, when around 75% of nephrons are lost, this is when creatinine starts to increase outside of its reference interval (however it tends to progressively increase within the reference interval far before this – but this is very difficult to pick up)

73
Q

Markers of Renal Function

A

USG- Decreased urine concentrating ability is often seen in CKD- a number of animals (especially cats) can have a normal USG despite reduced renal function so it is not an overly accurate assessment

UP:C- Reflecting tubular and/or glomerular damage (see glomerular disease/proteinuria lectures)
Phosphate- Dysregulated in CKD and part of the IRIS staging system
Blood pressure – Increased in the majority of animals with CKD and needs addressing
PCV/HCT – Can be decreased in advanced CKD and may need addressing
pH – Metabolic acidaemia often present in advanced CKD
FGF-23 – a novel biomarker

74
Q

IRIS CKD Staging System

A

International Renal Interest Society (IRIS) have produced a staging system for CKD
Typically based on creatinine concentration, but more recently SDMA has been incorporated
Also takes into account phosphate, proteinuria, and hypertension
Provide management advice for different CKD stages
Stage I CKD – Evidence of chronic changes to the kidney when creatinine is within the RI
Stage II+ CKD – As above, but with increasing creatinine concentrations outside the RI
THE IRIS CUT-OFFS ARE NOT REFERENCE INTERVALS
The diagnosis of CKD is based on YOUR LABORATORIES RI and then staged based on the IRIS CKD cut-offs!

Cases typically fall into two categories
1- Animals presenting due to clinical signs of uraemia
2- Incidentally discovered increased filtration markers (creatinine/SDMA) on routine/pre-anaesthetic blood-work
Clinical signs do not tend to be present until IRIS stage III/IV (unless other comorbidities or acute on chronic are present) however signs can be seen at earlier stages, especially in smaller dogs*
Most common presentation is an older cat (often 10 years plus) with progressive loss of condition, dehydration, and hyporexia-anorexia.
The approach is the same in both categories, in both species

Clinical signs can also be seen unexpectedly in animals with lower IRIS stages when the degree of muscle mass has ‘falsely’ lowered creatinine concentrations (note, SDMA would not typically be expected to result in reduced muscle mass)

The majority of cats over the age of 15 will have some degree of chronic kidney disease. Consequently, the older feline cat with CKD is probably the most common presentation of CKD you will see in practice and consequently the lecture will focus mainly on this although the approach is similar in the dog. As there are a wide number of causes of CKD in dogs and cats there is inevitable a wide range of presentations!

75
Q

Presentations of CKD in Companion Animals- Clinical Examination

A

Varying clinical signs depending on the severity of azotaemia (and thus uraemia)
Typically, uraemia will lead to signs of nausea and hyporexia-anorexia
This results in reduced water intake  dehydration (and perpetuation)
The reduced calorie intake results in muscle and condition loss
May also notice a ‘uraemic’ smell to the breath and/or oral ulceration
May also have small or irregular kidneys on palpation
Note – CKD also includes conditions that can be non-azotaemic (e.g. glomerular disease, or renal tubular dysfunction) that may have a completely different spectrum of clinical signs

The oral ulceration can often be vague ‘redness’/discolouration at the edges of the tongue

76
Q

treatment of ckd

A

As discussed, in some cases the presentation will be such that it is almost unequivocally CKD although the changes have not been documented for 3 months. So very much the initial investigations in the case are going to be very similar to the investigations of AKI (see AKI lectures)

Again, in cases where CKD is highly likely, some of the ongoing management is likely to be started prior to this three-month point

initial investigations should be focued in esablishing type of ckd- Investigate specific or ‘treatable’ causes- radiograph/ ultrasound

should also establish-
Baseline Creatinine, Phosphate, Calcium, Haematology ± SDMA
Urinalysis, UP:C, urine culture
Doppler Blood pressure

As these cases technically present as an AKI – then investigations into underlying or specific causes should be performed – see AKI lecture
Marked proteinuria (~≥2.0) should prompt investigations into underlying glomerular disease
Imaging (abdominal radiographs and ultrasound) to assess likelihood of CKD, alongside specific causes (neoplasia, PCKD, ureteroliths etc.)
A positive urine culture on presentation (using tissue breakpoints) should be treated as pyelonephritis
Baseline bloodwork should be performed to look for causes/comorbidities but will need to be rechecked at three months to assigns IRIS stage

SDMA if creatinine is not within the reference interval or if severe muscle wastage and concern of ab ility of creatinine to accurately reflect IRIS stage.
Please note, although SDMA is better able to determine the IRIS stage in the presence of marked muscle wastage – the difference in treatment recommendations between IRIS stage is minimal and it could be considered academic to focus so heavily on SDMA (cf. creatinine) in these circumstances

Animal presents with presumed CKD-> Baseline creatinine or SDMA (based on laboratory cut-offs)-> Investigations into presumed CKD-> Monitor for three-months ± treatment-> Assign IRIS CKD Stage based on IRIS cut-offs

77
Q

managment of chronic kidney disease

A

Nutrition and maintaining hydration

Managing Hyperphosphataemia

Managing Proteinuria

Managing Hypertension

Other management considerations

When we have reached the three month mark and have confirmed CKD (any stage) we begin management*
It is important to note that, for the vast majority of cause of CKD – There is NO treatment
Management is aimed at slowing on-going deterioration and maintaining/improving quality of life
Most animals will continue to have a progressive decrease in renal function although a proportion will remain stable for long periods of time
Again, it is exceptionally rare to see an improved in renal function
Outlined in IRIS CKD guidelines

78
Q

Management of CKD – Nutritional Management

A

There are two main aspects as to the nutritional management of CKD:
1- Maintaining calorie intake
2- Transition on to a renal diet
Hyporexia-Anorexia is common in IRIS stage III/IV and modifications are typically required to ensure adequate calorie intake
Protein-energy wasting can result in worsening uraemia and poorer quality of life
Maintaining hydration should be encouraged alongside

Renal diets have been shown to improve survival of dogs and cats with CKD by 2-3 times
Consequently, mainstay of management of CKD in both species
However, it is generally considered more important that an animal maintains calorie intake rather than insufficient calorie intake from a renal diet
“The wrong calories are better than no calories”
Dry and Wet products available (wet preferred)
Range of different products on the market including ‘combination’ diets
Recent introduction of ‘early’ renal diets

Although the exact features differ between renal diet, they typically share the following features
Moderately restricted, high-quality protein source – Reduction in proteinuria and uraemic toxins
High Calorie Density- Improve calorie intake
Low phosphate- Reduction of plasma phosphate concentrations
Fortification with Omega 3 Fatty acids- Maintenance of lean body mass and possible anti-inflammatory effects
± Potassium supplementation- Hypokalaemia can be seen in late stage CKD
± Bicarbonate supplementation – Metabolic acidosis can be seen in late stage CKD

It can often take time to find a renal diet that the animal will eat
Slow transitioning (especially in cats) can help with transition- in some cases you may need to transition over ‘1 kibble at a time’ over a period of weeks to months
Adding water to dry food may improve uptake
Clients will often add cooked meat to the diet – proactively advise against this
In theory, starting a renal diet prior to development of uraemia may help improve acceptance
Use of medical management may be beneficial
In advanced stages, assisted enteral feeding may be required

79
Q

Management of CKD –Nutrition- Medical management

A

Medical management can be used when ‘conservative’ approaches have failed
Mirtazapine has been the mainstay in cats for management of anorexia and nausea (poorer effect in dogs)
Dose reduction is recommended in CKD:
- 2mg/CAT/PO q24-48hr

Transdermal product available with a ‘smoother’ profile and fewer adverse effects - not as good for appitie
Capromorelin is an excellent appetite stimulant with long-term safety studies- blood prssure lowers. dog version needs to be imported
- 2-3mg/KG/PO q24hr

Ondansetron has good anti-nausea properties that may help appetite but is not an appetite stimulant (see AKI lectures)

Vitamin B12 supplementation can be considered- often low kidney cases

Gastroprotectants should ONLY be used if high suspicion of gastrointestinal bleeding- previously gastroprotectants have been routinely recommended in dogs and cats with CKD due to a suspicion of uraemic gastric ulceration. However, more recent studies suggest that the incidence of such lesions is uncommon and thus routine gastroprotectants are not recommended

80
Q

Management of CKD –Maintaining Hydration

A

In advanced stages, animals with CKD are at risk of dehydration
Plentiful and accessible water provision should be provided at all times
Animals with advanced CKD may need intermittent periods of hospitalisation for IV rehydration
Placement of oesophagostomy feeding tube or owner-provided subcutaneous fluids can also be considered
Recent release renal-friendly water flavour-enhancer that increases water intake in cats- Note, the only research for this product is by the company who made the product and only investigated the product in healthy cats. Avoid using tuna-water or chicken broth as this has high inorganic phosphate concentrations that has been shown to be detrimental to the kidneys

81
Q

Management of CKD – Nutritional Management- Early Renal Diets

A

Recent introduction of ‘early’ renal diets
Lower degrees of phosphate and protein restriction
Limited research currently but suggested benefit for:
1- Animals in IRIS Stage I (± early stage II CKD)
2- Animals in IRIS Stage I/II with increased FGF-23 concentrations that indicate inadequate phosphate restriction
3- Animals that have developed hypercalcaemia after starting a ‘standard’ renal diet
Early renal diets should be avoided in presence of proteinuria above the IRIS reference intervals

82
Q

Management of CKD – Managing Hyperphosphataemia

A

Phosphate concentrations on presentation correlate with survival
Reduction in phosphate concentrations may improve outcome in CKD
Note, the target phosphate concentration is LOWER than the normal phosphate reference interval
Dietary phosphate restriction is trialled first. If after six weeks the target concentration is not achieved, phosphate binders are indicated
FGF-23 concentrations MAY help identify animals that require additional phosphate reduction in excess of the IRIS guidelines

The ideal plasma phosphate concentration in CKD is 0.9-1.5mmol/l however after IRIS stage II this can be increasingly difficult to achieve. Consequently, more ‘realistic’ targets are provided for increasing IRIS stages

If after six weeks of a renal diet phosphate targets are not achieved, phosphate binders are indicated
Phosphate binders MUST be given with food- cant bind the phosphate of the food if not given at the same time

Two main types:
1- Aluminium based – E.g. Alu-caps
- Risk of aluminium toxicity – monitor for microcytosis and neurological signs

2- Calcium based – E.g. Pronefra, Ipakitine
- Avoid in hypercalcaemia
Newer human products likely to reach veterinary market (lanthanum, sevelamer etc.)
Re-check after 4-6 weeks

Note- although aluminium phosphate binders used to be the mainstay of treatment for hyperphosphataemia in CKD – they seem to be becoming less available from veterinary medicine wholesalers

83
Q

phosphate binders

A

reduce phosphate to manage ckd

If after six weeks of a renal diet phosphate targets are not achieved, phosphate binders are indicated
Phosphate binders MUST be given with food- must interact with the food to bind the phosphate
Two main types:
1- Aluminium based – E.g. Alu-caps
- Risk of aluminium toxicity – monitor for microcytosis and neurological signs

2- Calcium based – E.g. Pronefra, Ipakitine
- Avoid in hypercalcaemia
Newer human products likely to reach veterinary market (lanthanum, sevelamer etc.)
Re-check after 4-6 weeks

84
Q

Management of CKD – Managing Proteinuria

A

Proteinuria is commonly seen in CKD and can be glomerular and/or tubular in origin
Proteinuria on presentation is correlated with survival and treatment of proteinuria is likely to improve outcome
Identification and management of proteinuria is covered in the proteinuria/glomerular disease lectures
Proteinuria should be checked for persistence (confirmed twice in a six-week period) before treatment is initiated
Pre-renal and post-renal inflammation should also be ruled out
IRIS Proteinuria targets and treatments differ between dogs and cats
- Dogs: <0.5 (or 50% reduction in UP:C)
- Cats: <0.4 (or 50% reduction in UP:C)

Mainstay of treatment is RAAS inhibitors alongside renal diet
In dogs, an angiotensin receptor blocker (ARB) is recommended first line
In cats, an ARB OR an ace-inhibitor (ACEi) is recommended first line
Dose escalated until targets are reached OR adverse effects outweigh the benefits
Blood-pressure, creatinine, and electrolytes should be checked 7-14 days after initiation or change in dose of RAAS inhibitors
CARE in advanced CKD as may markedly worsen uraemia*
Benazepril (ACEi)
- 0.5mg/kg/PO q12hr
Telmisartan (ARB)
- 1mg/kg/PO q24hr
RAAS inhibitors (ACEi/ARBs) MUST be discontinued in dehydrated/unwell animals – THIS MUST BE COMMUNICATED TO CLIENTS!

85
Q

RAAS inhibitors for ckd

A

In dogs, an angiotensin receptor blocker (ARB) is recommended first line
In cats, an ARB OR an ace-inhibitor (ACEi) is recommended first line
Dose escalated until targets are reached OR adverse effects outweigh the benefits
Blood-pressure, creatinine, and electrolytes should be checked 7-14 days after initiation or change in dose of RAAS inhibitors

Benazepril (ACEi)
- 0.5mg/kg/PO q12hr

Telmisartan (ARB)
- 1mg/kg/PO q24hr

RAAS inhibitors (ACEi/ARBs) MUST be discontinued in dehydrated/unwell animals – THIS MUST BE COMMUNICATED TO CLIENTS!

86
Q

Management of CKD – Managing Hypertension

A

Hypertension can occur at any CKD stage and at any time- non-azotaemic animals can still be hypertensive due to renal disease (e.g. glomerular disease).
Hypertension can contribute to on-going deterioration in renal function and can also lead to target organ damage (cardiac, ophthalmic, neurological etc.)
Important to aim to get reliable blood pressure measurements (although not possible in all animals)
Treatment depends on species
Aim is to reduce blood pressure to <160mmHg

see ACVIM Hypertension Guidelines 2018 for what to do and how often to measure blood prssure

87
Q

Hypertension treatment dogs

A

( in order of choice)
ACEi – e.g. benazepril (0.5mg/kg/PO q12hr)*
Increased dose of ACEi
Addition of amlodipine (0.1-0.25mg/kg/PO q24hr)
Combination ACEi/amlodipine

The current recommendation for treating hypertension in dogs is to use an ACEi as first line treatment (cf. proteinuria which is an ARB). ARBs have a similar anti-hypertensive effect to ACEis in dogs so they can be considered as an alternative and is in-line with the ACVIM hypertension guidelines. Furthermore, it is not uncommon to have a dog where an accurate blood pressure cannot be acquired for varying reasons. However, if the animal is proteinuric, there is merit for starting an ARB and thus also likely addressing blood pressure at the same time

88
Q

Hypertension treatment cats:

A

( in order of choice)

Amlodipine (0.1-0.25mg/kg/PO q24hr) OR ARB (telmisartan – 2mg/kg/ PO q24hr)
Increase dose of amlodipine
Combination therapy
Remember to monitor blood pressure, creatinine, and electrolytes 7-14 days after initiation/dose change

89
Q

Management of CKD – Other Considerations- Anaemia

A

Anaemia can be seen in advanced CKD and can contribute to malaise
Rule out ‘other’ causes of anaemia (e.g., gastrointestinal bleeding)
Treat when PCV is <0.20l/l (20%) or convincing related clinical signs
Treatment is Erythropoietin and iron supplementation (some cases may require transfusion)
Anabolic steroids (e.g., Laurabolin) are of no proven benefit and may be detrimental

90
Q

Management of CKD – Other Considerations- Nephrotoxic Drugs

A

Drugs with potential nephrotoxicity should be discontinued and avoided
In advanced stages of CKD, drug-dose reductions should be considered (outside expected new-graduate competency)
Complex situation with NSAIDs
NSAIDs can be directly and indirectly nephrotoxic
However, some studies suggest a benefit in feline CKD-However, this remains controversial. One study even suggested a benefit in feline CKD however this is likely not to be the case and NSAIDs should not be used for this justification
The pros and cons should be weighed up carefully alongside close monitoring.
Consider less nephrotoxic alternatives

91
Q

Management of CKD – Other Considerations-
Positive Urine Cultures

A

On initial presentation of CKD (technically AKI), positive urine cultures should be treated as pyelonephritis
Tissue break-points should be applied to determine culture and sensitivity
Marbofloxacin 2mg/kg/PO q24hr for 14 days (or based on C+S)
Future positive urine cultures should be treated if:
- Signs suggestive of LUTD (treat as UTI)- amoxycillan
- Signs suggestive of pyelonephritis (treat as pyelonephritis)
- Sudden increase in creatinine (treat as pyelonephritis)
- Pyrexia or neutrophilia that cannot be attributed to another cause (treat as pyelonephritis)
Otherwise, do not treat asymptomatic positive urine cultures

92
Q

treatment for pylonephritis

A

Marbofloxacin 2mg/kg/PO q24hr for 14 days (or based on C+S)

93
Q

Management of CKD – Other Considerations-
Electrolyte and Acid-base

A

Hypokalaemia can be seen in advanced CKD, especially in cats
Contributes to lethargy, anorexia, and muscle weakness
Oral supplementation with potassium gluconate or potassium citrate

Hypercalcaemia (total or ionised) can develop in a number of animals with CKD over time – this can be complex to investigate/treat – get specialist advice

Acidaemia – metabolic acidosis can develop in advanced CKD contributing to muscle wastage/anorexia – consider potassium citrate/sodium bicarbonate- Neither of these are palatable and can be difficult to administer (consider giving with food or in a gelatine capsule

94
Q

Monitoring of CKD

A

After diagnosis of CKD, frequency of monitoring is determined by IRIS stage
Rechecks involve (on a starved sample):
Clinical examination (BCS/MCS/Hydration)
Creatinine (± Urea)
Phosphate
Electrolytes
UP:C (± culture)
Doppler Blood pressure
PCV
± Acid-base
± Ionised Calcium
± FGF-23
Some of these will be performed more frequently depending on medication dose changes/additions

shuld be monitored acording to iris stage-
1- 6 monthly
2- 3-6 monthly
3- 1-3 monthly
4- 1-2 monthly

95
Q

Prognosis of CKD

A

Somewhat dependent on underlying cause and whether glomerular component
In ‘idiopathic’ CKD, when consuming a renal diet, very rough prognoses are given
Acute on Chronic CKD likely has a worse prognosis and ‘speeds up’ deterioration
Some animals will have stable creatinine for long-periods of time (do not give clients false hopes!)- some stay in stge 2 for whole lives
Severity of manifestations of CKD generally becomes pronounced from IRIS stage III+, but can be seen at earlier stages

prognosis acording to iris stage

cats- 1- unknown
2- 2-3 years
3- 1-2 years
4- 1-3 months

dogs-
1- >1year
2- 1-1.5 years
3- 3-7 months
4- 1-2 months

96
Q

Dialysis and Renal Transplantation

A

In animals that are not able to maintain their normal renal homeostasis despite medical management then dialysis or renal transplantation is indicated
Although dialysis is available in the UK at one centre (RVC) this is only available for AKI
Renal transplantation available in the US and owners must adopt the donor cat
Veterinary renal transplantation is currently against the law in the UK

97
Q

SDMA as a kidney marker

A

SDMA is a biomarker of glomerular filtration and typically increases prior to creatinine
Furthermore, less influenced by factors such as muscle mass
Best placed to diagnose CKD but creatinine is a better marker of progression
Increased SDMA but normal creatinine – treat as IRIS Stage I CKD*
There is generally no benefit for measuring SDMA when creatinine is increased
However, may allow more accurate staging of CKD in presence of reduced muscle mass - ?clinical relevance?

98
Q

FGF-23

A

A new renal biomarker has recently been released for use in cats – FGF-23
FGF-23 is involved in mineral-bone disease in CKD
Increases prior to parathyroid hormone and is able to comment on adequacy of phosphate restriction – ‘going that bit further’
Indications:
Assessment of adequacy of phosphate restriction when in target range
Need for early renal diet in IRIS Stage I/II CKD
Guidance for interpretation provided by IDEXX

99
Q

Predicting CKD – RenalTech

A

Machine learning approach to the prediction of the development of CKD in cats*
Offers prediction of likelihood of cat developing CKD over next two years
Highly specific – if predicts that the cat will develop CKD there is a high chance it will
Very poorly sensitive – if predicts that the cat will NOT develop CKD there is still a high chance it can do
Predictive ability improves the ‘closer’ to the development of clinically recognisable CKD
This is likely to be a growing field in veterinary medicine although should be interpreted cautiously – difficult to recommend routinely currently

N.b., the study that looked at the accuracy of this prediction algorithm was performed by the company who own the laboratory that provide the test- furthermore, based on an American rather than UK feline population

100
Q

Oliguria

A

Relative reduction in urine output

101
Q

intrinsic aki

A

where there is damage directly to the kidney

102
Q

Pre-renal AKI

A

results from a decrease in perfusion to the kidneys -> reduction in GFR -> an increase in SDMA/Creatinine/Urea

If severe enough/present for long enough can lead to intrinsic AKI

Due to either:

1- Reduced afferent perfusion- Hypotension, hypovolaemia, shock etc.

2- Increased efferent venous congestion- Cirrhotic liver disease, Right sided heart failure, fluid overload

Both tend to have normal-milder increases in creatinine (~140-300μmol/L) that is rarely hyperkalaemia/oliguria/anuric and tends to rapidly respond to treatment of underlying cause
However, can result in a secondary INTRINSIC AKI that can present more severely

103
Q

Post-Renal AKI

A

results from obstruction of the urinary tract -> increased tubular pressures -> reduction in GFR -> an increase in SDMA/Creatinine/Urea
N.b. urinary tract rupture can also be classed as Post-renal AKI but the azotaemia occurs via different mechanisms
If severe enough/present for long enough can lead to intrinsic AKI

Due to:
Urethral obstruction
Ureteral obstruction
Urinary tract rupture

Cases of post-renal AKI are much more likely to be hyperkalaemic
Presence of hyperkalaemia should be a red-flag for searching for obstructive causes!
See obstructive nephropathy lecture which also covers treatment of hyperkalaemia

104
Q

intrinsic aki- ischaemic

A

reduced perfusion to the kidneys leading to intrinsic AKI. Any cause of hypotension or shock (e.g., anaesthesia, sepsis, blood-loss, severe diarrhoea etc.)

105
Q

intrinsic aki- Infection

A

Pyelonephritis – Infection of the kidneys
Pyonephrosis – Dilation of renal pelvis with pus
Uncommon cause of AKI (<2%), but increased prevalence in acute on chronic kidney disease
Most common infectious agent is Escherichia coli
Also consider Leptospirosis and Borrelia burgdoferi*
Risk factors include urinary tract obstruction, diabetes mellitus, renal and non-renal neoplasia.

Borrelia burgdoferri (lyme nephritis) CAN cause a very severe glomerulonephritis. HOWEVER, this presentation of Lyme borreliosis appears to be much less common in the UK and Europe compared to America

106
Q

intrinsic aki- Glomerulonephritis

A

Damage to the glomeruli

107
Q

Diagnosing AKI

A

History - Mechanism of injury (MOI) likely to result in AKI (e.g. Toxin exposure or sepsis)

Clinical signs- Uraemia, dehydration, or as a result of underlying MOI

Biochemistry – New increases in creatinine or SDMA (care re: urea)

Urinalysis- Proteinuria, glucosuria, cylinduria, reduced urine output after rehydration

Imaging – Evidence of ischaemia or obstruction

Generally speaking, in animals with AKI without uraemia (i.e. their severity of their azotaemia is not so marked as to result in clinical signs)

Urea/BUN can be affected by a wide range of causes, many of which are not directly related to kidney function (e.g. pyrexia or dehydration) – so I personally would be extremely hesitant to diagnose an AKI based on urea alone (unless SDMA was increased or creatinine was increase within the reference interval although outside of the reference interval)

However, overall, creatinine is going to be your main one for diagnosis AKI

108
Q

IRIS grade I AKI

A

includes animals with creatinine typically within the reference interval

Non-azotaemic (absent signs of uraemia- Although the animal can have few to no signs of uraemia, there may be other non-uraemic signs present such as hypertension, glucosuria, etc. ), increase in creatinine (≥ 26.4 μmol/L) within the RI
- oliguria/anuria
- Imaging changes consistent with AKI
- Urine changes consistent with AKI (proteinuria, cylinduria, glucosuria,etc.)

109
Q

IRIS Grade II+ AKI

A

Increasing severity of azotaemia (typically above the reference interval) ± combinations of the above

110
Q

treatment of AKI

A

“There is not much you can do to help AKI, but there is a lot you can do that is detrimental”

Excluding cats with urethral obstruction, the majority of the cases of AKI you will see in primary care practice will not have an identifiable cause
After ruling out causes of AKI that require specific treatments the treatment of the remaining causes of AKI is largely supportive
The aim is to support the animal to see IF an adequate degree of renal recovery can occur by the three-month mark at which point it will undergo CKD staging

The majority will not have an identifiable cause, most likely because the cause has ‘been and gone’ and you are left picking up the pieces.

Animal Presents with AKI-> Rule out causes that require specific treatments -> Provide supportive care -> CKD stage at three-month mark

Causes of AKI that MUST be investigated:
urgent (within hours)- Obstructive AKI
Infectious AKI
Hypoadrenocorticism (D)- Please note, hypoadrenocorticism is NOT strictly a cause of intrinsic AKI but tends to cause a pre-renal AKI (but this can lead to an intrinsic AKI). However, the biochemical and electrolyte changes associated with hypoadrencorticism can very closely mimic AKI so when I am presented with an animal with AKI, I will always rule out hypoadrenocroticsm in DOGS because I have been caught out previously!

less urgent (within days)- Neoplasia
Glomerulonephritis

their absence, treatment is supportive

111
Q

causes of AKI that require specific treatment

A

urgent (within hours)- Obstructive AKI
Infectious AKI
Hypoadrenocorticism (D)- Please note, hypoadrenocorticism is NOT strictly a cause of intrinsic AKI but tends to cause a pre-renal AKI (but this can lead to an intrinsic AKI). However, the biochemical and electrolyte changes associated with hypoadrencorticism can very closely mimic AKI so when I am presented with an animal with AKI, I will always rule out hypoadrenocroticsm in DOGS because I have been caught out previously!

less urgent (within days)- Neoplasia
Glomerulonephritis

112
Q

Clinical presentation of pyelonephritis

A

‘Traditionally’ we would suspect pyelonephritis in any animal that presents with an AKI and has a combination of:
Pyrexia
Neutrophilia often with left shift/toxic-changes
Renal pain
Renal pelvic/ureteral dilation and/or peri-renal hyperechogenicity or free-fluid* on ultrasound- peri-renal free fluid is relatively common in animals with leptospirosis

More recently, studies have suggest that these ‘classic’ signs are not as common as first thought and can be more ‘subtle’
Consequently, currently recommend to treat every AKI case with a positive urine culture as pyelonephritis

113
Q

Diagnosis of pyelonephritis:

A

Diagnosis of pyelonephritis:
A positive urine culture from the renal pelvis is the ‘gold standard’

Cystocentesis urine sample is an adequate alternative (in non-obstructive AKI)- EVERY AKI case should have a urine culture with tissue breakpoints- It is important that you submit urine in both a plain tube, boric acid, and charcoal swab (as false negatives can occur during transport, even with same-day lab collection) – it is imperative that you ask the laboratory to perform culture and sensitivity testing with tissue breakpoints so that they can assess the susceptibility of bacteria within the renal tissue (otherwise the laboratory assumes that the concentration of the antibiotic is much higher due to urinary concentrating).

  • Primary decision making for immediate use of IV antimicrobials is based on sepsis criteria (see sepsis lectures)

In absence of sepsis signs, base on clinical suspicion OR positive urine culture
De-escalate antimicrobials if culture-negative
N.b., different antimicrobial choices for Leptospirosis

114
Q

Treatment of pyelonephritis:

A

Treatment of pyelonephritis:
Based on meeting sepsis criteria:
25mg/kg/q6hr IV Amoxicillin clavulanate
5mg/kg IV once marbofloxacin (then 2mg/kg/24hr IV thereafter)

AMOXICILLIN CLAVULANTE should NOT be used ALONE for pyelonephritis as it has POOR renal parenchymal penetration (even if the culture and sensitivity result suggest it is sensitive!).

Marbofloxacin is given as a ‘one off’ loading dose of 5mg/kg IV and then continued as 2mg/kg/q24hr IV. The duration of treatment for sepsis depends somewhat on clinical improvement.

When an animal has been diagnosed as pyelonephritis purely based on C+S (i.e, there were no sepsis signs to warrant treatment on initial presentation but the C+S results returned positive) then marbofloxacin (or other appropriate antimicrobial based on C+S) should be given for 14 days

It is somewhat recommend to repeat urine cultures 1-2 weeks following cessation of antimicrobial treatment for pyelonephritis. HOWEVER, there is a possibility that this may just reflect ‘bacteriuria’ so unless the initially clinical suspicion was very high, this may not be overly necessary.

Based on clinical suspicion/positive urine culture:
2mg/kg/q24hr IV/PO marbofloxacin for 14 days (or based on C+S)

Pyonephrosis:
As above, but requires urgent surgical drainage (referral procedure)

115
Q

treatment of leptospirosis

A

5mg/kg/q12hr PO Doxycycline for 14 days
or
25mg/kg/q8hr IV Amoxcillin clavulanate until doxycycline course can be tolerated

116
Q

Approach to the animal with AKI- Hypoadrenocorticism

A

HA is not generally considered a cause of AKI however does cause a marked pre-renal azotaemia
Also often get hyperkalaemia and hyperphosphataemias
Consequently, in every DOG with an AKI, I check basal cortisol to screen for HA
A basal cortisol >55nmol/L* rules out HA
If a very high suspicion, do an ACTH stimulation test and treat presumptively

Please note this cut off has ONLY been validated on the immulite 2000 and Tosoh AIA360 analsyers – i.e. only if you send to an external laboratory. In-house analysers have NOT been validated for this cut-off point. However, if your basal cortisol is >100nmol/L, it is probably unlikely that the animal has HA

117
Q

Approach to the animal with AKI- Neoplasia

A

MOST cases of renal neoplasia will present as CKD.
However, might be difficult to differentiate between first presentation of CKD and AKI
Perform POCUS in every AKI case
Renal lymphoma in cats can result in bilateral changes and relatively-normal architecture
FNA of kidneys MAY detect renal neoplasia and should be considered in cases with a clinical suspicion and where clotting-ability permits it

Please note, renal FNA is ONLY accurate for neoplasia (and even then is not that accurate) – renal biopsies are needed for all other conditions. Furthermore, renal biopsies require very special handling and MUST only be sent to the European (Italy) or American veterinary renal pathology services (DO NOT send renal biopsies to other laboratories). It is STRONGLY ADVISED to discuss the need for renal biopsies with an veterinary internal medicine specialist before considering them.

118
Q

Approach to the animal with AKI- Glomerular Disease

A

Glomerular disease can present as both an AKI or CKD
Some AKIs as a result of glomerular disease can be rapidly progressive
The hallmark of glomerular disease is proteinuria and is typically ≥ 2.0
Every AKI should have urine protein:creatinine ratio (UP:C) performed
However, UP:C can be temporarily increased in AKI for a range for of reasons so need to re-check twice in a six week period*
25-50% of cases of glomerular disease in dogs and cats may benefit from immunosuppression so important to check- discuss with internal medicine specialist

Please note, glomerular disease can exist at UP:C magntiudes even as low as <0.5. However, those that typically result in AKI’s are often >2.0.
We can also see high UP:C as a result of inflammation and UP:Cs can also be increase

*pre and post-renal inflammation can result in temporarily increased UP:C hence why you need to re-check the proteinuria TWICE in a six week period. However, if you have progressive azotaemia, hypoalbuminaemia, or nephrotic syndrome – it is worth speaking to an internal medicine specialist as some cases may benefit from immunosuppressive medication.

119
Q

tests for suspected aki

A

Haematology and Biochemistry
Cystocentesis urine for urinalysis, UP:C, culture and sensitivity
POCUS ± FNA
Doppler Blood Pressure
±Basal cortisol (dogs)
± Acid-base analysis
± Leptospirosis tests
± Investigations into comorbidities in ‘AKI’

Please note, glomerular disease can exist at UP:C magntiudes even as low as <0.5. However, those that typically result in AKI’s are often >2.0.
We can also see high UP:C as a result of inflammation and UP:Cs can also be increase

120
Q

Treatment of AKI

A

Treatment of AKI:
Once we have ruled out causes that require specific treatment (or alongside treatment) the remainder of treatment for AKI is supportive

The overall aim is to support the animal until (/IF) it manages to achieved a sufficient amount of renal recovery to maintain the following aspects of homeostasis on its own:
Water balance (hydration)
Electrolyte balance
Acid-base balance
Nutrition

We then wait to see what degree of renal function is left ‘when the dust settles’ (/IF) at the three-month mark where we assess its CKD stage.

121
Q

Maintaining Hydration - Fluid therapy in AKI

A

Fluid therapy in AKI
Fluid therapy is an important aspect of the treatment for AKI and involves ensuring that an animal’s water requirements are met to avoid dehydration
However, a ‘Goldilocks’ approach is needed as animals with renal disease are highly susceptible to fluid overload
When we get to a point where an animal with AKI is able to drink adequate amounts of water and not become dehydrated (i.e., maintain its own hydration), then fluid therapy MAY no longer be indicated
Some causes of AKI (toxins) MAY warrant higher rates of fluid therapy
Some post-renal obstructive causes of AKI MAY develop post-obstructive diuresis necessitating higher rates of fluid therapy (see obstruction lecture)
Paying close attention to fluid therapy is most critical in oliguric/anuric animals

Stage of fluid therapy:
R- Resuscitation – Replacing intravascular deficits (rarely required in primary AKI- If AKI is the main presenting complaint, then it is uncommon for animals to require resuscitation of their intravascular volume (e.g., in a ‘primary’ intrinsic AKI) however in AKI is secondary to other cuass (e.g. sepsis) then intravascular resuscitation might be required. )

O – Optimisation – Rehydrating total body water deficits

S- Stabilisation – Providing maintenance water requirements IF an animal is not able to do so itself

E – Evacuation – De-escalation of fluid therapy

122
Q

Fluid therapy in AKI- Stages of Fluid Therapy- Resuscitation

A

R- Resuscitation – Replacing intravascular deficits
IF an animal presents with signs of reduced intravascular volume (e.g., Shock) then fluid boluses are required to improve this (see ECC lectures)
Typically 5-10ml/kg boluses of Balanced Crystalloid (e.g. Lactated Ringer’s) over 15-20 minutes until end-points are met
The use of 0.9% NaCl is discouraged
This is rarely required in AKI

123
Q

Fluid therapy in AKI- Stages of Fluid Therapy- Optimisation

A

O- Optimisation – Repleting total body water deficits
It is not uncommon for animals with an AKI to present as dehydrated
The optimisation phase involves replacing these losses of 6-8 hours*
Base on clinical assessment of hydration
Typically using balanced crystalloid solution (e.g. Lactated Ringer’s)
Frequent, re-assessments of hydration status to avoid overhydration**

124
Q

Fluid therapy in AKI- Stages of Fluid Therapy- Stabilisation

A

S- Stabilisation – Continue to provide maintenance water requirements IF required
At this stage, we are attempting to provide on-going water requirements if an animal is not able to maintain hydration through oral intake
Typically, this is using maintenance fluid rates (1-2ml/kg/hr)- Please note, that the mtainenance fluid rates are AVERAGE WATER requirements for the animal for the day. In fact, an animals’ ACTUAL water requirement varies MASSIVELY, and is typically lower in animals that rae not eating. Consequently, and as per the rehydration (optimisation) phase, it is important to continually assess the animal for signs of overhydration

0.45% NaCl is preferred owing to its lower sodium concentration, otherwise Balanced electrolyte solution (E.g., lactated ringers)
26-30mmol/L KCl supplementation is also recommended in non-hyperkalaemic animals
Frequently attempt to reduce the rate to avoid overhydration with frequent hydration assessments
?Need/accuracy? Of ‘ins-outs’ approach in non-oliguric/anuric animals?

125
Q

Fluid therapy in AKI- Stages of Fluid Therapy- Evacuation

A

E- Evacuation – De-escalation of fluid therapy
When an animal is either drinking* on its own or expected to do so- A phrase that is often used in veterinary medicine is “fluids until eating” however there is very little rationale behind this statement as animals will quite commonly drink when they are not eating. Consequently, do not use/rely on the phase “fluids until eating” as there is no evidence behind this.
Important to note that animals will often fail to drink until they are 0.5% dehydrated so may not drink whilst on IV fluids
When deemed safe to do so, slowly decrease the fluid rate by 25% every 8-12 hours and assess for any evidence of overall dehydration or deterioration
Ensure that the animal is then able to maintain its hydration status on oral intake alone
Do not base fluid requirement on changes in creatinine concentrations

126
Q

Fluid therapy in AKI- Oliguria/Anuria and the ‘Ins-Outs’ approach

A

Oliguria – relative/partial reduction in urine output
Anuria – complete reduction in urine output
Can occur with ANY grade of AKI
Presence of oliguria/anuria can only be assessed once an animal is in the maintenance phase of fluid therapy
More likely to occur with causes that also cause hyperkalaemia
MARKED risk of fluid overload in these animals
Requires rapid recognition and strict fluid therapy assessment

The ‘ins outs’ approach:
Aim to balance total fluid input with total fluid lost

Fluid in:
Oral intake and IV Fluids
Water in nutrition (especially if assisted enteral feeding)
Medications, CRIs, IV-flushes etc.

Fluid out:
Insensible losses – respiration, salivation, faeces, wounds etc.
Sensible losses – Urination/drains

Volume of fluid lost (insensible + sensible) is replaced with TOTAL fluid in
Insensible losses are ~0.75ml/kg/hr
Sensible losses are calculated from urine output
Often requires indwelling urinary catheter or weighing bedding/litter trays (1g = 1ml)
However, this is a very rough estimate and if you start ‘overhydrated’ can lead to ‘chasing up’ fluid volume.

For example:
10kg dog
Insensible losses = 7.5ml/hour
Sensible losses (urine) = dog has produced 40ml of urine in the last four hours = 10ml/hour
Total losses – 17.5ml/hour
Non-fluid ‘ins’: 2ml per hour from IV flushes, 5ml from CRIs, 10ml from O.tube feeds = 17ml/hour
Therefore, IV fluid required to match ‘losses’ = 0.5ml hour (out – ins = 0.5ml)
However, need to frequently monitor the animal for dehydration or fluid overload

127
Q

Management of AKI- Nutrition

A

Animals with an AKI are typically hyporexic-anorexic often as a result of uraemia -> nausea/vomiting
Presence of oral ulceration (uraemic ulcers) may also contribute as well as concurrent illness
Medical therapy (anti-nausea, appetite stimulants) may help address this
If animal cannot consume at least 75% of its required calorie intake by 48 hours, will need assisted enteral feeding (see nutrition lectures)

128
Q

Treatment of AKI- Anti-Nausea Medication

A

Nausea typically results from build-up of uraemic toxins can be improved with anti-nausea medication

Maropitant – very good anti-emetic, but poor anti-nausea
- 1mg/kg IV q24hr or 2mg/kg PO q24hr

Ondansetron – very good anti-nausea, but poor anti-emetic
- 0.5-1mg/kg IV/PO q8hr (can be given with maropitant)
- N.b., can risk serotonin syndrome if given alongside mirtazapine

Gastroprotectants are NOT recommended unless there is convincing evidence of gastrointestinal bleeding

129
Q

Treatment of AKI- Appetite Stimulants

A

Appetite stimulants can help improve appetite
Capromorelin – 3mg/kg PO q24hr
- Excellent appetite stimulant with wide safety profile

Mirtazapine – 2mg/CAT/PO q48hr
- Excellent appetite stimulant in cats (poorer in dogs) with anti-nausea properties
- Risk of serotonin syndrome if given alongside ondansetron
- Both capromorelin and mirtazapne can be given together

Vitamin B12 – (250μg/animal/SC or IM once)
- Can be considered as an appetite stimulant

There is some rationale to vitamin b12 given that it is a water soluble vitamin and diuresis may lead to lower concentrations. Currently, it also generally considered to be ‘safe’ to administer empirically as a ‘one off

130
Q

Treatment of AKI - Hypertension

A

Blood pressure:
A notable proportion of animals with an AKI will be hypertensive on presentation and a greater proportion will develop this during hospitalisation
Treatment of hypertension is complex as some anti-hypertensive medications may be considered nephrotoxic
If systolic blood pressure >160mmHg AND/OR evidence of target organ damage*  treat

In THESE cases* – amlodipine 0.05mg/kg/q24hr PO

Otherwise, repeat BP assessment twice over next eight weeks (see CKD lecture)

In the CKD lectures we discussed about using RAAS inhibitors (acei/arbs) to treat systemic hypertension. However, in AKI these are verging on contraindicated due to the risk of a precipitous drop in glomerular filtration rate and a risk of worsening renal damage. Consequently, in AKI only, treatment of hypertension is recommended with Amlodipine (however, if the animal progresses to CKD this should be re-evaluated and RAAS inhibitors re-considered).

Target organ damage typically refers to:
Ocular – retinal detachment or haemorrhage
Neurological – vestibular signs or seizures

Normally, we would treat high blood pressure in dogs with ACEi/ARBs. However, as these can drop GFR, especially at higher values of creatinine, they should be avoided in AKI until GFR has reduced/is more stable. Consequently, the first line treatment for hypertension in AKI is amlodipine in BOTH dogs and cats(second line is hydralazine) (note this part of the 2023 IRIS AKI consensus and differs from the ACVIM consensus on hypertension of any cause).

Do not use Ace inhibitors or angiotensin receptor blockers in AKI cases as these MAY result in worsening renal function

131
Q

Treatment of AKI – Electrolyte abnormalities

A

Electrolyte abnormalities:
Electrolyte abnormalities are not uncommon in AKI cases

Hyperkalaemia – is more commonly seen in obstructive causes of AKI (see obstruction lectures)

Hypokalaemia – can be seen on presentation or during hospitalisation
- This should be treated with IV supplementation or oral supplementation (e.g., potassium citrate)

Hyperphosphataemia – is almost always present in AKI, although its treatment in the ‘acute’ should only be started once enteral nutrition has been achieved (see CKD lectures)-Do not give phosphate binders on an empty-stomach

Hypernatraemia – can be present on admit due to dehydration or can develop during hospitalisation following the use of ‘high sodium’ fluids (use 0.45% NaCl in maintenance phase to avoid this)

132
Q

Treatment of AKI- Discontinuation of Nephrotoxic Drugs

A

Nephrotoxic drugs should be discontinued and avoided in AKI
‘Classic’ examples include:
- NSAIDs*
- Amphotericin B
- Aminoglycosides
- Allopurinol (more insidious progression)
- ACEis and ARBs (RAAS inhibitors)
- ?Intravenous contrast agents?
However, possibility for idiosyncratic reaction to ANY drug – consider any recently started medications as a potential cause of AKI and consider withdrawal/substituted?
Consider dose changes for drugs that undergo renal excretion

Please note, this is in contrast to CKD where NSAIDs can be considered in select cases

ACEis and ARBs may not directly cause AKI but may decrease GFR with potentially marked exacerbation of uraemia

Intravenous contrast agents have historically been considered to be nephrotoxic however more recent evidence suggests this is not the case

133
Q

Treatment of AKI – Prognosis and Time frames

A

The aim of treatment of AKI is to get an animal to a point where (/IF) it can achieve an adequate degree of renal recovery that allows it to maintain overall homeostasis on its own (± medications)
It will take on average 1-3 weeks before an improvement is seen- excluding TREATED pre-renal, post-renal (obstructive), pyelonephritis/leptospirosis causes of AKI. This does not mean that the animal will necessarily need to be in the hospital for this period of time, just do not overly expect to see rapid changes in creatinine – this will typically occur over the subsequent weeks!
Do not expect to see an improvement in creatinine within the first week of hospitalisation (although if it does improve, the prognosis is likely favourable)
Note changes in creatinine during hospitalisation may just be reflective of dilution from fluid therapy
Creatinine concentration on presentation is poor predictor of survival
Oliguria/Anuria is a negative prognostic indicator
Overall survival is around 50% but highly dependent on cause of AKI

IF can get animal to a point where can maintain its homeostasis at home, monitor over the subsequent three months (e.g., 1 week, 1 month, and 3 months)
- Repeat assessments of creatinine, electrolytes, phosphate, blood pressure, UP:C
At the three-month mark, if creatinine is stable, assign an IRIS CKD STAGE (see CKD lectures)
Unfortunately, a proportion of animals will not make it to this point and will deteriorate in the meantime

134
Q

supportive care for aki

A

Maintaining Hydration
Maintaining Calorie Intake
Assessing for, and treating systemic hypertension
Addressing electrolyte and acid-base derangements
Other Supportive care

135
Q

Toxic causes of AKI

A

There are a number of toxic causes (or potential causes) of AKI that you will commonly come across in primary care practice
These include:
Grapes/Raisins (dogs)- Grapes/Raisans have been seen to cause clinical signs in cats but these are usually gastrointestinal signs rather than acutekidney inury
Lillies (cats)
Ethylene glycol – almost invariably fatal by the time AKI develops
NSAIDs
Myoglobin/haemoglobin
(see toxicology lectures)

There is some theoretical evidence as to providing increased fluid rates in toxic causes of AKI - especially in haemoglobin/myoglobin
Majority of textbooks will recommend increased fluid rates in toxic causes of AKI
Consequently, based on the current (limited) veterinary research, it is likely professionally safer to follow these guidelines for suspected toxic causes of AKI
However, continue to monitor for evidence of fluid overload or relative oliguria/anuria

hesitant to go higher then 4-6ml/kg/hr and would much prefer to use lower-sodium fluid such as 0.45% NacL but monitoring for hyponatraemia – this recommendation may change over time

136
Q

Leptospirosis as a cause of aki

A

Leptospirosis is not an uncommon cause of AKI in dogs
Typically seen in young, unvaccinated dogs
However, can also be seen in those who have only received Bivalent L2 vaccine
Presentation is very variable and likely serovar related
Think leptospirosis in any dog with a cholestatic pattern on biochemistry and AKI (but do not always have hepatic component!)
Not uncommon to be oliguric/anuric so be careful with fluids
Gold standard test is paired, rising MAT antibody titres- However these will take time to return and need to be taken 2-4 weeks apart, consequently, treatment is nearly always initiated pending a diagnosis

Marked cross-reaction with vaccine antibodies so in-house tests need to be interpreted cautiously- if an animal has been vaccinated against Leptospirossi within the last 6-12 months, the antibody tests will nearly always be the result of this (need to demonstrate a rising titre to confirm that this was cause of AKI) – this includes the point-of-care assays such as Witness or SNAPlepto
Will often need to treat presumptively based on clinical suspicion:
- 5mg/kg/q12hr PO Doxycycline for 14 days
- but if oral medication cannot be tolerated
- 25mg/kg/q6-8hr IV Amoxicillin clavulanate until doxycycline can be tolerated

137
Q

AKI - Myths

A

“Flushing the kidneys out”
- Traditionally, very high rates of fluids have been advised to attempt to ‘flush the toxins out’. Not only has this been shown to work, but both human and veterinary studies have shown that the resultant fluid overload to be severely detrimental – DO NOT DO IT!

“Changes in creatinine reflect improvement in kidney function”
- Although overall a decreasing trend of creatinine can suggest improvement in renal function, it can also just reflect ‘dilution’ by fluid therapy
- This typically causes confusion when fluid therapy is reduced from a higher rate with a resultant mild increase in creatinine – this typically just reflects ‘reduced dilution’

138
Q

AKI - Dialysis

A

In cases of AKI or CKD where the degree of renal dysfunction is so severe that medical treatment is unable to maintain homeostasis within ‘liveable’ parameters- dialysis is indicated.
Dialysis acts as an ‘external kidney’ allowing time to see IF the native kidneys can improve to a degree that is compatible with life
The typical indications can be remembered by the ‘vowels’:
A- Acidaemia
E- Electrolyte abnormalities (typically potassium)
I- Intoxication (e.g., Ethylene glycol)
O- Overload (fluid)
U- Uraemia
Currently (2023) only one centre in the UK offers dialysis (RVC) and only for AKI cases
Not uncommon to require weeks of treatment and typically in the tens of thousands of pounds*
May be prudent, professionally, to discuss options with clients in cases where dialysis is indicated

Leptospirosis cases anecdotally improve a lot quicker and may be cheaper
It is not uncommon for animals to be referred to the RVC where the clinical decision is that dialysis is not currently indicated and medical treatment is continued – do not promise that dialysis will be performed!

139
Q
A